Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Cash-and-Equivalents" stands at 574.30 Billion Japanese Yens as of 06/30/2025.
As of the end of Daiichi Sankyo Co. Ltd.'s first quarter, the item "Cash and Equivalents" stands at 574.30 Billion JPY. This represents an increase of 56.29 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -28.68 percent compared to the value the year prior.
The 1 year change in percent is -28.68.
The 3 year change in percent is -12.73.
The 5 year change in percent is 50.30.
The 10 year change in percent is 140.88.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash and Equivalents | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash and Equivalents | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash and Equivalents | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash and Equivalents | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Cash and Equivalents | 280,205,508,085.11 |